Overview
This bill amends Texas state law to expand and regulate the scope of practice for licensed midwives. It allows midwives to administer certain drugs during labor and postpartum care, establishes new training requirements, and clarifies prohibited practices. The legislation aims to enhance midwifery services while maintaining safety standards and defining clear boundaries of practice.
Core Provisions
The bill amends the Texas Occupations Code to allow licensed midwives to administer specific drugs commonly used in labor and postpartum care, including antihemorrhagic drugs, intravenous fluids, local anesthetics, and prophylactic drugs for women and newborns. It requires midwives to complete training in newborn screening, drug administration, and basic life support cardiopulmonary resuscitation. The legislation prohibits midwives from using forceps or surgical instruments except for cutting the umbilical cord or emergency first aid, removing placenta by invasive techniques, or using mechanical devices or medicines to advance or retard labor. It also mandates that midwives hold current CPR certification. The bill establishes a new continuing education requirement in pharmacology for license renewal.
Key Points
- Allows midwives to administer specific drugs during labor and postpartum care
- Requires training in newborn screening, drug administration, and CPR
- Prohibits use of forceps, invasive placenta removal, and labor-altering devices/medicines
- Mandates CPR certification and continuing education in pharmacology
Legal References
- Texas Occupations Code §203.256
- Texas Occupations Code §203.3525
- Texas Occupations Code §203.302
- Texas Occupations Code §203.401
Implementation
The Texas Commission of Licensing and Regulation is tasked with adopting rules to implement the new provisions by December 1, 2025. The Department of State Health Services is responsible for approving certain prophylactic drugs that midwives can administer. The bill does not specify funding mechanisms or detailed reporting requirements. Compliance will be enforced through the existing midwife licensing and renewal process, with new requirements taking effect for license renewals after February 1, 2026. The legislation does not explicitly outline enforcement provisions beyond the existing regulatory framework for midwives in Texas.
Impact
The primary beneficiaries of this legislation are licensed midwives in Texas, who will have an expanded scope of practice, and their clients, who may receive more comprehensive care during labor and delivery. The bill is likely to increase administrative burden on the Texas Commission of Licensing and Regulation and the Department of State Health Services, which must develop new rules and approve certain drugs for midwife use. Midwives will face increased training and certification requirements, potentially leading to higher costs for maintaining their licenses. The expected outcome is improved midwifery care with clearer guidelines on permissible practices. No specific sunset provisions are included in the bill.
Legal Framework
The bill operates within the existing statutory framework for regulating healthcare professions in Texas, specifically amending Chapter 203 of the Texas Occupations Code. It expands the regulatory authority of the Texas Commission of Licensing and Regulation and the Department of State Health Services over midwifery practice. The legislation does not appear to preempt local laws or address judicial review. It explicitly states that the administration of drugs by midwives under the new provisions does not constitute the practice of medicine as defined in Subtitle B of the Occupations Code, potentially avoiding conflicts with medical practice regulations.
Critical Issues
Implementation challenges may arise in developing appropriate training programs and pharmacology courses for midwives within the specified timeframe. There could be potential conflicts or overlap with existing medical regulations, particularly regarding the administration of prescription drugs. The bill may face opposition from medical professionals concerned about expanding the scope of practice for non-physician practitioners. Cost implications for midwives to meet new training and certification requirements could impact the availability of midwifery services. There may be unintended consequences related to liability and insurance coverage for midwives administering drugs and performing newly authorized procedures.